Navigation Links
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Date:7/17/2008

(TT) business

were previously reported in the BioScience business. The TT business

was sold on February 28, 2007. The TT totals above include sales of

TT products through the date of divestiture, as well as revenues

associated with manufacturing, distribution and other services

provided by the company to the buyer of the TT business post-

divestiture.

Baxter International Inc.

Key Product Line Sales

Periods Ending June 30, 2008 and 2007

(unaudited)

($ in millions)

--------------------------------------------------------------------------

% Growth % Growth

@ @

Q2 Q2 Actual Constant

2008 2007 Rates Rates

--------------------------------------------------------------------------

--------------------------------------------------------------------------

BioScience

Recombinants $508 $431 18% 10%

Plasma Proteins 291 243 20% 12%

Antibody Therapy 315 238 32% 27%

Regenerative Medicine (1) 109 87 25% 17%

Other (2) 162 191 (15%) (27%)

--------------------------------------------------------------------------

Total BioScience (3) $1,385 $1,190 16% 8%

--------------------------------------------------------------------------

--------------------------------------------------------------------------'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
2. Baxters Board of Directors Declares Quarterly Dividend
3. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
4. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
5. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
6. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
7. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
8. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
9. Baxter Declares Quarterly Dividend
10. Baxter Provides Update on Heparin Reactions
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... MILWAUKEE, Wis. (PRWEB) , ... July 29, 2015 ... ... facility identification solutions, today announced its GHS Label Guide . To align ... Harmonized System (GHS), this guide includes explanations of label components, an example of ...
(Date:7/29/2015)...  Therapath Neuropathology ( www.Therapath.com ), a leader ... and Military Medical centers both domestically and worldwide.  ... Sweat Gland Nerve Fiber Density (SGNFD) for the ... Demonstration of a reduction in ... skin biopsy is a highly sensitive and specific ...
(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... announce that the final design specifications of its ... for industrial and regulatory testing will now be ... mark clearance to market the injector in ... (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  The RCI-02 ...
Breaking Biology Technology:Brady Announces a New GHS Label Guide 2Neuropathology services for VA and Military health systems 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5
... Jr., will address attendees regarding the implementation of Homeland ... www.ndia.org/meetings/9860 on January 27-28, 2009 at the Sheraton National Hotel ... ... 13, 2009 – General Victor E. Renuart, Jr., Commander, ...
... Link, Ph.D., of RainDance Technologies, Inc., will present ... a discussion of the commercialization of the use ... in the life sciences, at the LabAutomation2009 conference ... Calif.RainDance Technologies is a provider of innovative microdroplet-based ...
... Bionics Inc., "Victhom" (TSX: VHB), announced today the filing ... of sleep apnea and has also disclosed the preliminary ... recently filed a new patent application relating to a ... of sleep apnea/hypopnea using its neuromodulation platform. Late in ...
Cached Biology Technology:DoD Leader to Address Presidential Biometrics Security Directive at NDIA Conference 2DoD Leader to Address Presidential Biometrics Security Directive at NDIA Conference 3'Biology in Pico-Liter Droplets' is Focus of Presentation at LabAutomation 2009 2'Biology in Pico-Liter Droplets' is Focus of Presentation at LabAutomation 2009 3Victhom announces the completion of the second phase of the apnea therapy development 2Victhom announces the completion of the second phase of the apnea therapy development 3
(Date:7/21/2015)... OXFORD, Connecticut , July 21, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... the Wocket® smart wallet, announces that it has ... Tokenization System and Method. This ... that not only authorizes an account, but also ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... mercury is high and increasing in fish in the North ... elsewhere in the Arctic. But a team of scientists ... is wrong in much of the continental Arctic. In ... diverse atmospheric, geological, and biological conditions, "It turns out that ...
... RENO - A new collaborative research project funded by ... Obrist at the Desert Research Institute (DRI) will attempt ... of the Earth,s northernmost and most fragile ecosystems. ... environment, but human activities such as fossil fuel combustion, ...
... Inc. (OTC.BB:HEPI.OB News), in conjunction with Wayne ... in the College of Liberal Arts and Sciences, ... the Journal of Nutrition & Metabolism , ... hamsters, while inhibiting production of betaine, carnitine, and ...
Cached Biology News:Virginia Tech research overturns assumption about mercury in the Arctic 2Virginia Tech research overturns assumption about mercury in the Arctic 3New DRI project aimed at understanding Mercury dynamics in the Arctic tundra 2Wayne State cholesterol study shows algal extracts may counter effects of high fat diets 2Wayne State cholesterol study shows algal extracts may counter effects of high fat diets 3
... enzyme mix (Thermoprime Plus DNA Polymerase with ... four times higher fidelity than standard Taq ... Taq DNA polymerase, Amplifies DNA templates >20kb, ... PCR, PCR for cloning and mutagenesis We ...
RNA oligomers from 10 to 50 bases purified by PAGE and MS-checked. RNAs are supplied dried and fully deprotected....
... Incubator/Shaker HT is designed for ... Incubator/Shaker HT is ideal for ... and primer extension assays. The ... as a one-cabinet model, allowing ...
... is a modified cap analog in which ... is replaced with OCH3. Because of this ... transcription with the remaining hydroxyl group thus ... As a result, unlike transcripts synthesized with ...
Biology Products: